Kevelt AS
🇪🇪Estonia
Clinical Trials
3
Active:2
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
1
CIMA_AEMPS:1
Drug Approvals
VAZOSTENON 20 MICROGRAMOS/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
- Approval Date
- Jul 14, 2025
CIMA_AEMPS
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CA
- First Posted Date
- 2014-02-17
- Last Posted Date
- 2017-01-24
- Lead Sponsor
- Kevelt AS
- Target Recruit Count
- 8
- Registration Number
- NCT02064725
- Locations
- 🇺🇸
Physicians Research Group, San Jose, California, United States
🇺🇸St. Jude Hospital Yorba Linda, St. Joseph's Heritage Healthcare, Santa Rosa, California, United States
🇺🇸Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
News
No news found